Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16161108 | 1.00 | ALDH1A1 (0.31) | ALDH1A1TSHR | |
| SCHEMBL16161096 | 1.00 | ALDH1A1 (0.31) | ALDH1A1TSHR | |
| SCHEMBL16161158 | 1.00 | ALDH1A1 (0.31) | ALDH1A1TSHR | |
| SCHEMBL16161135 | 1.00 | ALDH1A1 (0.31) | ALDH1A1TSHR | |
| SCHEMBL16161165 | 1.00 | ALDH1A1 (0.31) | ALDH1A1TSHR | |
| SCHEMBL16161157 | 0.98 | — | — | |
| SCHEMBL16161241 | 0.90 | — | — | |
| SCHEMBL16161246 | 0.79 | — | — | |
| SCHEMBL16161213 | 0.76 | — | — | |
| SCHEMBL9633790 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2789602-B1 | Omega-halo-2-alkynal, method for producing the same, and method for producing conjugated Z-alken-yn-yl acetate using the same | SHINETSU CHEMICAL CO (JP) | 2017-12-27 | — | — | EP | disclosed |
| US-9550720-B2 | Method for producing an ω-halo-2-alkynal | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-01-24 | — | — | US | disclosed |
| US-9376368-B2 | Method for producing a conjugated Z-alken-yn-yl acetate | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-06-28 | — | — | US | disclosed |
| US-20160107978-A1 | METHOD FOR PRODUCING A CONJUGATED Z-ALKEN-YN-YL ACETATE | SHINETSU CHEMICAL CO (JP) | 2016-04-21 | — | — | US | disclosed |
| US-20160107969-A1 | METHOD FOR PRODUCING AN OMEGA-HALO-2-ALKYNAL | SHINETSU CHEMICAL CO (JP) | 2016-04-21 | — | — | US | disclosed |
| US-9255056-B2 | Omega-halo-2-alkynal | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-02-09 | — | — | US | disclosed |
| US-20140309452-A1 | OMEGA-HALO-2-ALKYNAL, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING CONJUGATED Z-ALKEN-YN-YL ACETATE USING SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-10-16 | — | — | US | disclosed |
| EP-2789602-A1 | Omega-halo-2-alkynal, method for producing same, and method for producing conjugated Z-alken-yn-yl acetate using same | SHIN-ETSU CHEMICAL CO., LTD (JP) | 2014-10-15 | — | — | EP | disclosed |
| EP-0241335-B1 | 1-SUBSTITUTED CONJUGATED ALKA-(E,Z)-DIENE COMPOUNDS AND A METHOD FOR THE PREPARATION THEREOF | Shin-Etsu Chemical Co., Ltd. (JP) | 1992-06-03 | — | — | EP | disclosed |
| EP-0241335-A1 | 1-substituted conjugated alka-(E,Z)-diene compounds and a method for the preparation thereof | Shin-Etsu Chemical Co., Ltd. (JP) | 1987-10-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140309452-A1 | OMEGA-HALO-2-ALKYNAL, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING CONJUGATED Z-ALKEN-YN-YL ACETATE USING SAME | NOTUM, SOAT2, FASN | ALDH1A1 641/4885TSHR 1718/4885 |
| US-20160107969-A1 | METHOD FOR PRODUCING AN OMEGA-HALO-2-ALKYNAL | HACL2, FASN, ALOX5 | ALDH1A1 754/4885TSHR 1670/4885 |
| US-20160107978-A1 | METHOD FOR PRODUCING A CONJUGATED Z-ALKEN-YN-YL ACETATE | HACL2, FASN, ZYX | ALDH1A1 742/4885TSHR 1278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.